FILTERED RESULTS
FILTERS
Ads Top
DARK MODE
CHART
    Filters
      Symbols
      Sentiment
      Impact
      Search
      FILTERED RESULTS

        

      Upgrade your plan

      Abbott Laboratories Reports Earnings Beat Amid Stock Decline

      Abbott Laboratories announced its first-quarter earnings, surpassing analysts' expectations with adjusted earnings of $1.15 per share, slightly above the forecast of $1.14. The company's sales also increased by 3.7% on a comparable basis, reaching $11.16 billion, which was marginally higher than the anticipated $11 billion.

      Despite the positive earnings report, Abbott's stock experienced a decline on Thursday. This downturn is attributed to ongoing challenges in one of its business segments and the impact of a dilutive acquisition. Investors reacted negatively to these factors, overshadowing the earnings beat.

      © 2026 KLEA News. All Rights Reserved. This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.

      Source: KLEA News

      .

      Terra Founder Do Kwon Sentenced to 15 Years in Prison for Fraud